Procter & Gamble Health Limited (NSE:PGHL)
India · Delayed Price · Currency is INR 4,801.50
+2.70 (0.06%)
Apr 1, 2026, 3:29 PM IST
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 79.65 billion as of April 1, 2026. Its market cap has decreased by -9.24% in one year.
Market Cap
79.65B
Enterprise Value
76.85B
Revenue
13.49B
Ranking
n/a
PE Ratio
27.14
Stock Price
4,801.50
Market Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 79.65B, an increase of 717.24%. That is a compound annual growth rate of 8.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 79.65B | -15.84% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 185.77B |
| NATCO Pharma | 175.29B |
| Alembic Pharmaceuticals | 132.40B |
| Alivus Life Sciences | 120.38B |
| Cohance Lifesciences | 115.80B |
| Strides Pharma Science | 86.67B |
| Akums Drugs and Pharmaceuticals | 72.62B |
| Sudeep Pharma | 68.55B |